Organoidsciences Ltd. (KOSDAQ:476040)
South Korea flag South Korea · Delayed Price · Currency is KRW
31,700
-500 (-1.55%)
At close: Aug 27, 2025

Organoidsciences Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-13,280-11,246-38,687-24,111
Depreciation & Amortization
1,3661,3041,144804.46
Loss (Gain) From Sale of Investments
-284.29-163.05-43.05-
Stock-Based Compensation
1,021969.5979.19542.39
Other Operating Activities
213.6479.1529,85313,990
Change in Accounts Receivable
-11.71149.39-393.50.78
Change in Inventory
26.8226.82-26.23-
Change in Accounts Payable
0.740.7414.88-
Change in Income Taxes
--0.74-
Change in Other Net Operating Assets
-1,064-260.43-90.48256.22
Operating Cash Flow
-12,013-9,141-7,248-8,518
Capital Expenditures
-1,244-667.07-947.83-1,787
Sale of Property, Plant & Equipment
--6.16-
Sale (Purchase) of Intangibles
-124.58-120.21-70.5-16.88
Investment in Securities
-13,8345,7615,632-25,434
Other Investing Activities
-70.94-48.27-19.93-1,094
Investing Cash Flow
-15,2734,9254,600-28,332
Short-Term Debt Issued
-3,000-300
Long-Term Debt Issued
-700--
Total Debt Issued
3,7003,700-300
Short-Term Debt Repaid
--300--
Long-Term Debt Repaid
--217.49-218-231.04
Total Debt Repaid
-543.14-517.49-218-231.04
Net Debt Issued (Repaid)
3,1573,183-21868.96
Issuance of Common Stock
24,818200250-
Other Financing Activities
236.03280.79148.42218.27
Financing Cash Flow
28,2113,663180.4311,286
Foreign Exchange Rate Adjustments
8.7544.82-74.93-
Net Cash Flow
932.92-507.22-2,543-25,563
Free Cash Flow
-13,257-9,808-8,196-10,304
Free Cash Flow Margin
-525.93%-502.11%-515.13%-2351.33%
Free Cash Flow Per Share
-2430.37-2346.59-2859.93-3595.68
Cash Interest Paid
336.29301.32341.67123.02
Cash Income Tax Paid
--34.04114.09-
Levered Free Cash Flow
--68,92415,049-
Unlevered Free Cash Flow
--66,93018,794-
Change in Working Capital
-1,049-83.47-494.59257
Source: S&P Global Market Intelligence. Standard template. Financial Sources.